📣Calling all #AHFTC Fellows! . @CircHF is proud to launch a free educational webinar series for current or past AHFTC fellows. 📍8 live virtual sessions, 1 in-person event.📍New topic each session . 📅Start Date: August 13, 2025. 🔗Learn More:

Adding HCTZ to furosemide in acute HF increases hypokalemia risk, especially if K⁺ <4.3 or not on MRA therapy @jc_trullas @HeartFailure @IcyfaSEMI #AHAJournals

Sex Differences in Utilization of Donation After Circulatory Death Donors for Heart Transplantation and Associated Outcomes @NirUrielMD @ersied727 @DhariniRamu @elenamdonald @rcogswell_umn #AHAJournals

Narrowing the Gap: Addressing Sex-Based Factors in VA-ECMO Care @mhillmd @VorovichHeartMd #AHAJournals

2/ Catheter-based AAV5 delivery enabled efficient, safe gene transfer in large animal hearts. Post-MI AAV5-hS100A1 preserved LVEF & modulated key pathways. 🔗 #GeneTherapy #HeartFailure #AAV5 #CardioTwitter @janek_salatzki @johannesriffel @wallyjoe33

1/ 🧬 Cardiac-targeted AAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in post-ischemic hearts . .

🚨New study in #HFpEF: It's not how much muscle you have—but how your muscles use energy.⚡. Older HFpEF patients had worse exercise tolerance & outcomes despite similar muscle mass—due to impaired skeletal muscle energetics. 🧠 A new metabolic target?.🔗

2/ @JR_Goldenberg @docsabe @JohnsHopkinsDOM @Hopkins #AHAJournals

1/ Skeletal Muscle Quantity versus Quality in Heart Failure: Exercise intolerance and outcomes in older HFpEF patients are related to abnormal skeletal muscle metabolism rather than age-related skeletal muscle loss . .

Eosinophilic myocarditis in a child caused by Toxocara canis. Diagnosis via MRI & biopsy; early treatment was lifesaving. #PedsCardio #PedsID @M_OConnorC @HugoMartinezMD @DellMedSchool @Jason_N_Johnson #AHAJournals

👉 No difference in outcomes between male and female patients after VA-ECMO for cardiogenic shock: HYPO-ECMO trial findings! @hvanspall @GuiBaudry @NicolasGirerd #AHAJournals

In children with hypertrophic cardiomyopathy, their neighborhood and environment impact their peak exercise capacity @DrRossMasood @JonEdwardsMD #AHAJournals

High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy @matser89 @aldoporcari @TiniGiacomo @GSaturi @LauraDemichieli @albcipri6 #AHAJournals

Incoming, current & early-career attendings (within 2 years of fellowship completion) are encouraged to register. Program includes:.📍 Eight 60-90 minute live, virtual sessions led by national and international experts.📍 1 in-person networking & learning event during #AHA25.

Are you an incoming #AHFTC Fellow? . @CircHF is hosting a free educational webinar series for fellows looking to:.📍Expand clinical knowledge.📍Make meaningful peer & mentor connections.📍Get exposure to the editorial & research environment of #CircHF.🔗

📢Expedited Review for #ESCCongress 2025!.@CircHF invites authors with accepted ESC presentations to submit manuscripts for rapid review. 📍Initial decisions within 10 days! .📝Submit by June 23 .🔗Learn More: #AHAJournals @DrNancySweitzer @JamesCFangMD

RT @CircImaging: 📢 Expedited Review for #ESCCongress 2025!.@CircImaging invites authors with accepted ESC presentations to submit manuscrip….

RT @CircOutcomes: 🚨ICYMI🚨 @CircOutcomes is inviting submissions for a special issue: “Cardiovascular Epidemiology: From Findings to Impact”….

🚨ICYMI: Incoming Advanced HF Fellows & Early-Career attendings are encouraged to register for the @CircHF Educational Webinar Series. 📌 See the full list of webinar topics here: 📅Start Date: August 13, 2025. #AHAJournals @AHAScience @dor_lotan.

RT @CircHF: This course is designed to:.➡️ Expand your clinical knowledge. ➡️ Facilitate meaningful peer and mentor connections. ➡️Provide….

RT @CircHF: 📣Calling all #AHFTC Fellows! . @CircHF is proud to launch a free educational webinar series for current or past AHFTC fellows.….